Investigative Ophthalmology & Visual Science Cover Image for Volume 63, Issue 7
June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Post-hoc simulation study to optimize performance of the computer adaptive EyeQ
Author Affiliations & Notes
  • Petra Rausch - Koster
    Ophthalmology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands
    Ophthalmology, Bergman Clinics BV, Naarden, Noord-Holland, Netherlands
  • Frank D. Verbraak
    Ophthalmology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands
  • Ger M.H.B. van Rens
    Ophthalmology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands
  • Ruth M A van Nispen
    Ophthalmology, Amsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, Netherlands
  • Footnotes
    Commercial Relationships   Petra Rausch - Koster None; Frank D. Verbraak None; Ger M.H.B. Rens None; Ruth van Nispen None
  • Footnotes
    Support  Bayer BV (IM20112/VUmc PROM)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4268. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Petra Rausch - Koster, Frank D. Verbraak, Ger M.H.B. van Rens, Ruth M A van Nispen; Post-hoc simulation study to optimize performance of the computer adaptive EyeQ. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4268.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In previous research the EyeQ item bank which measures vision-related quality of life (Vr-QoL) was developed and calibrated for future use as a computer adaptive test (CAT). In theory, the CAT-algorithm uses only a few items for a reliable Vr-QoL estimation (‘ability’), reducing patient burden. But before using a CAT in clinical practice it is essential to conduct preliminary analyses to evaluate the appropriateness of patient ability estimations (θ) against full test length and actual test length reduction. The aim of the current study was to optimize performance of the CAT-EyeQ by customizing stopping rules.

Methods : Post-hoc CAT simulations were performed using real responses. Patients (N=704, mean age 76.2), having macular edema due to several exudative retinal diseases completed the EyeQ (46 items). θ’s were estimated after fitting Samejima’s graded response model. Subsequently, plausible responses were imputed and again θ`s based on complete data were obtained. Pearson`s correlation was calculated between EyeQ θincom (incomplete data) and EyeQ θimput (plausible imputed data). Four CAT simulations were performed which varied in combinations of stopping rules: for CATDefaultPROMIS, a minimum and maximum length of 4 and 12 items, and an accuracy level of 0.32 (4|12|0.32) was set; for CATAlt1 2|15|0.32 and for CATAlt2 4|12|0.25. CATBesthealth was defined as CATDefaultPROMIS plus abort if the first four responses were rated as ‘best possible health’. Mean test length, percentage unreliably estimated CAT θ`s and mean standard error was evaluated. The conditional standard error across different levels of ability was examined graphically.

Results : Pearson`s correlation between EyeQ θincom and EyeQ θimput was 0.99. CATDefaultPROMIS showed the lowest mean number of items needed to administer (6.9), where CATAlt1 showed the lowest amount of unreliably estimated CAT scores (11.5%). CATAlt2 performed worst; mean number of items needed (9.7) and 37% unreliable estimations. Outcomes of CATBestHealth were similar to CATDefaultPROMIS, but further reduced the mean test length to 6 items. In all applied conditions, the conditional standard error was found to be highest at lower levels of ability.

Conclusions : This study shows that measuring Vr-QoL in clinical practice using the CAT-EyeQ with optimized stopping rules is useful as it leads to a higher measurement efficiency where reliable test outcomes can still be achieved.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×